Lixte Biotechnology Holdings, Inc. - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for Lixte Biotechnology Holdings, Inc. (LIXT) is 44.61M

According to Lixte Biotechnology Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 44.61M. This represents a change of -30.23% compared to the average of 63.93M of the last 4 quarters.

Lixte Biotechnology Holdings, Inc. (LIXT) Historical Enterprise Value (quarterly & annually)

How has LIXT Enterprise Value performed in the past?

The mean historical Enterprise Value of Lixte Biotechnology Holdings, Inc. over the last ten years is 5.64M. The current 44.61M Enterprise Value has changed 79.03% with respect to the historical average. Over the past ten years (40 quarters), LIXT's Enterprise Value was at its highest in in the June 2026 quarter at 99.97M. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.

Lixte Biotechnology Holdings, Inc. (LIXT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lixte Biotechnology Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lixte Biotechnology Holdings, Inc. (LIXT) Average Enterprise Value

How has LIXT Enterprise Value performed in the past?

The current Enterprise Value of Lixte Biotechnology Holdings, Inc. (LIXT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lixte Biotechnology Holdings, Inc. (LIXT) Enterprise Value vs. Peers

How is LIXT’s Enterprise Value compared to its peers?

Lixte Biotechnology Holdings, Inc.’s Enterprise Value is greater than Kairos Pharma, Ltd. (2.91M), greater than Lexaria Bioscience Corp. (2.05M), greater than Allarity Therapeutics, Inc. (23.76M), less than Cingulate Inc. (47.25M), greater than BriaCell Therapeutics Corp. (29.92M), greater than Pulmatrix, Inc. (3.07M), greater than Entero Therapeutics, Inc. (10.59M), greater than Hoth Therapeutics, Inc. (9.87M), less than Clearside Biomedical, Inc. (56.12M), greater than CASI Pharmaceuticals, Inc. (39.61M),

Build a custom stock screener for Lixte Biotechnology Holdings, Inc. (LIXT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lixte Biotechnology Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lixte Biotechnology Holdings, Inc. (LIXT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lixte Biotechnology Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.